BPCIA turns 10: Nearly 100 drugs become biologics

The law that opened up the approval pathway for biosimilars, known as the Biologics Price Competition and Innovation Act (BPCIA), turned 10 years old on Monday and nearly 100 drugs officially became biologics under what’s known as the “deemed to be a license” provision of the BPCIA.